Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nafamostat for Postreperfusion Syndrome in Liver Transplantation
NCT01001403Phase 4Completed
- Sponsor
- Seoul National University Hospital
- Start
- Mar 2009
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Nafabelltan in Post-reperfusion syndrome (PRS), sponsored by Seoul National University Hospital. Started Mar 2009; status: completed.
02
Drugs
Nafabelltan
03
Conditions
Post-reperfusion syndrome (PRS)
Beyond the preview
Go deeper on NCT01001403.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01001403.